Home/Companies/Merck & Co., Inc.

Merck & Co., Inc. (MRK) : key figures and financial history

Historical revenue, net income, net margin and earnings per share of Merck & Co., Inc., year by year from 2010 to 2025. Market data, amounts in US dollars.

Sector
Health
Country / place
🇺🇸 United States
Market cap
364,27 billion $
Price at 13/11/2026
147,76 $

Year-by-year financial history

Revenue, net income, net margin, earnings per share (EPS) and revenue growth. Amounts in USD.

YearRevenueNet incomeNet marginBPARevenue growth
201045,99 billion $861,00 M$1,9 %0,28 $n/d
201148,05 billion $6,27 billion $13,1 %2,06 $+4,5 %
201247,27 billion $6,17 billion $13,1 %2,20 $-1,6 %
201344,03 billion $4,40 billion $10,0 %1,50 $-6,8 %
201442,24 billion $11,92 billion $28,2 %4,20 $-4,1 %
201539,50 billion $4,44 billion $11,2 %1,60 $-6,5 %
201639,81 billion $3,92 billion $9,8 %2,07 $+0,8 %
201740,12 billion $2,39 billion $6,0 %0,95 $+0,8 %
201842,29 billion $6,22 billion $14,7 %2,40 $+5,4 %
201939,12 billion $9,84 billion $25,2 %3,84 $-7,5 %
202041,52 billion $7,07 billion $17,0 %2,79 $+6,1 %
202148,70 billion $13,05 billion $26,8 %5,16 $+17,3 %
202259,28 billion $14,52 billion $24,5 %5,73 $+21,7 %
202360,12 billion $365,00 M$0,6 %0,14 $+1,4 %
202464,17 billion $17,12 billion $26,7 %6,76 $+6,7 %
202564,93 billion $18,25 billion $28,1 %7,30 $+1,2 %

Revenue and net income evolution

Graphical representation of annual amounts (in USD).

20102012201420162018202020222024
RevenueNet income

Current ratios

Valuation and profitability; price ratios calculated based on the price of 13/11/2026.

P/E
46,03
PEG
1,81
EV/EBITDA
10,59
ROE
34,7 %
Debt / EPS
0,96
Yield
3,10 %
Methodology. The amounts (turnover, net income) are expressed in US dollars, converted at the 15/11/2026 exchange rate; the share price is displayed in its trading currency; ratios are currency-neutral. Revenue growth is calculated from one year to the next based on published real values. No value is estimated: a missing data point is noted as "n/d" or is not displayed. This information does not constitute investment advice. Share price and market capitalization as of 13/11/2026.